参考文献/References:
[1] 吴雪燕, 周遵伦, 张梅. 阴道微环境与人乳头瘤病毒感染及宫颈上皮内瘤变相关性的研究进展[J]. 贵州医药, 2021, 45(2):191-193. WU Xueyan, ZHOU Zunlun, ZHANG Mei,et al.Research progress of correlation between vaginal microenvironment and human papillomavirus infection and cervical intraepithelial neoplasia[J]. Guizhou Medical Journal,2021,45(2):191-193.
[2] OKUNADE K S. Human papillomavirus and cervical cancer[J]. Journal of Obstetrics and Gynaecology, 2020,40(5): 602-608.
[3] 张仕华, 孙辉, 杜彦丹. 人乳头瘤病毒感染与生殖器病变关系的研究进展[J].中国医药导报, 2020, 17 (4):48-51. ZHANG Shihua, SUN Hui, DU Yandan . Advancesin research on the relationship between human papillomavirus infection and genital lesions [J]. China Medical Herald,2020,17(4): 48-51.
[4] DE SANJOS? S, SERRANO B, TOUS S, et al. Burden of human papillomavirus (HPV)-related cancers attributable to HPVs 6/11/16/18/31/33/45/52 and 58[J].JNCI Cancer Spectrum, 2018, 2(4): pky045.
[5] CHIN-HONG P V, REID G E. AST infectious diseases community of practice. human papillomavirus infection in solid organ transplant recipients:guidelines from the American society of transplantation infectious diseases community of practice[J]. Clinical Transplantation,2019, 33(9): e13590.
[6] 杜伟平, 米思蓉, 王丽, 等. 延安地区妇女HPV 基因分型及临床相关研究[J]. 现代检验医学杂志, 2018,33 (1): 109-111, 114. DU Weiping, MI Sirong, WANG Li, et al. HPV genotyping and clinical studies of women in Yan’an area [J]. Journal of Modern Laboratory Medicine,2018,33(1):109-111, 114.
[7] 原荣, 李军, 南星, 等.陕西省宝鸡和咸阳两地妇女HPV 感染现状和类型分析[J]. 现代检验医学杂志,2017, 32(6): 145-146, 150. YUAN Rong, LI Jun, NAN Xing, et al. HPV prevalence and subtypes analysis of women in Baoji and Xianyang area of Shaanxi province [J]. Journal of Modern Laboratory Medicine,2017,32(6):145-150
[8] 原荣, 李军, 南星, 等.陕西省安康和延安两地区妇女HPV 感染及型别分布对比研究[J]. 现代检验医学杂志, 2017, 32(2): 64-66. YUAN Rong, LI Jun,NAN Xing,et al. Comparative study on HPV infection and hypotype distribution between Ankang and Yan’an area of Shaanxi province [J]. Journal of Modern Laboratory Medicine,2017,32(2):64-66.
[9] 龚娅, 段德令, 何雄, 等.广州地区女性泌尿生殖道HPV 感染特征及混合感染基因型分析[J]. 国际检验医学杂志, 2021, 42(10):1238-1241, 1245. GONG Ya, DUAN Deling, HE Xiong, et al. Analysis of HPV infection characteristics and mixed infection genotypes in female genitourinary tract in Guangzhou area [J]. International Journal of Laboratory Medicine,2021,42(10):1238-1241, 1245.
[10] 李翔, 马宁耶, 张瑶.4 万余例沈阳地区妇女HPV 感染情况分析[J]. 现代肿瘤医学, 2022, 30(5): 884-887. LI Xiang, MA Ningye, ZHANG Yao. Analysis of HPV infection in nearly 40 000 women in Shenyang [J].Journal of Modern Oncology,2022,30(5):884-887
[11] 吴道远, 刘慧, 陈广军, 等. 河南地区22 673 例女性HPV 感染状况及分型研究[J]. 检验医学与临床,2020, 17(23): 3404-3405, 3413. WU Daoyuan, LIU Hui, CHEN Guangjun, et al.Study on HPV infection status and typing of 22 673 women in Henan area[J]. Laboratory Medicine and Clinic,2020,17(23):3404-3405, 3413.
[12] 曹杰贤, 李雪菲, 沈国玲, 等. 云南7 个地区女性HPV 亚型感染情况调查[J]. 检验医学与临床, 2021,18 (6): 789-792. CAO Jiexian, LI Xuefei, SHEN Guoling, et al.Research of HPV subtype infection in 7 areas of Yunnan [J]. Laboratory Medicine and Clinic, 2021,18(6):789-792.
[13] EUN T J, PERKINS R B. Screening for cervical cancer[J]. Med Clin North Am. 2020, 104(6):1063-1078.
[14] 赵超, 赵昀, 崔淑慧, 等.子宫颈液基细胞学、高危型HPV 及联合检测在子宫颈癌机会性筛查中的价值[J].中国妇产科临床杂志, 2016, 17(2):119-121. ZHAO Chao, ZHAO Yun, CUI Shuhui, et al. Evaluation of cytology and HR-HPV test in cervical lesion opportunistic screening of women [J]. Chinese Journal of Clinical Obstetrics and Gynecology, 2016, 17(2):119-121.
[15] 徐帅师, 聂文佳, 张咏梅. 宫颈人乳头瘤病毒感染治疗方法研究进展[J]. 病毒学报, 2021, 37(3): 740-747. XU Shuaishi, NIE Wenjia, ZHANG Yongmei. Research progress in the treatment of cervical human papillomavirus infection [J]. Chinese Journal of Virology,2021,37(3):740-747.
[16] 陈婷婷, 汤雅玲. 厦门地区49 652 例女性高危型HPV 感染情况及年龄分布[J]. 中国现代医生, 2021,59(15):62-64. CHEN Tingting, TANG Yaling. High-risk HPV infection status and age distribution among 49 652 women in Xiamen[J]. China Modern Doctor, 2021, 59(15): 62-64.
[17] 王艳.液基细胞、HPV 检测与阴道镜宫颈癌的筛查方面的应用研究[J]. 中国医疗器械信息, 2018, 24(20):56-57. WANG Yan. Clinical application of liquid-based cytology, HPV-DNA or colposcopy in cervical cancer screening[J]. China Medical Device Information. 2018,24 (20):56-57.